- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.01. | Study finds weight returns more quickly in GLP-1 users | ||
| 08.01. | Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer | ||
| 08.01. | OpenAI launches ChatGPT Health portal | ||
| 07.01. | Hutchmed scores with drug for rare autoimmune disease | ||
| 07.01. | Is Lilly negotiating to buy Ventyx Bio? | ||
| 07.01. | Bayer's Monsanto sues mRNA COVID-19 vaccine makers | ||
| 07.01. | NICE endorses digital tools for people with asthma | ||
| 07.01. | GSK preps filings for chronic hepatitis B drug bepirovirsen | ||
| 06.01. | Amgen inks $840m takeover of UK's Dark Blue Therapeutics | ||
| 06.01. | Lilly taps Nimbus for another obesity candidate | ||
| 06.01. | Alumis shoots up as its Sotyktu rival aces psoriasis trials | ||
| 06.01. | More details emerge of NHS online hospital due next year | ||
| 06.01. | RNA specialist Ribo files $205m IPO in Hong Kong | ||
| 06.01. | CDC cuts recommended childhood jabs from 17 to 11 | ||
| 05.01. | Aktis Oncology files much-expanded IPO | ||
| 05.01. | Insilico adds Sanofi to partnership roster with $888m deal | ||
| 05.01. | China clears GSK's Nucala for COPD | ||
| 05.01. | Sanofi seeks use of type 1 diabetes drug in younger kids | ||
| 05.01. | Novo Nordisk launches Wegovy pill at $149 a month | ||
| 02.01. | NICE recommends wider use of Biogen MS drug via NHS | ||
| 02.01. | China delivers a win for Novo Nordisk on semaglutide IP | ||
| 02.01. | FDA declines to approve Corcept's rare disorder drug | ||
| 02.01. | Genmab ends lung cancer drug development | ||
| 31.12.25 | Vanda ends 40-year hiatus for new motion sickness drugs | ||
| 31.12.25 | Insilico ends 2025 with $293m Hong Kong IPO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.